✦ LIBER ✦

TREATMENT OF KERATOCONJUNCTIVITIS SICCA WITH LIQUID PARAFFIN OR POLYVINYL ALCOHOL IN DOUBLE-BLIND TRIALS

✍ Scribed by M. S. NORN

Book ID: 114920688
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Tongue: English
Weight: 226 KB
Volume: 55
Category: Article
ISSN: 1755-375X
DOI: 10.1111/j.1755-3768.1977.tb05675.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aripiprazole in the treatment of patient

Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone

✍ Martinotti, G; Di Nicola, M; Di Giannantonio, M; Janiri, L 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 182 KB

Effect of Treatment with Paromomycin on

Effect of Treatment with Paromomycin on Endotoxemia in Patients with Alcoholic Liver Disease—A Double-Blind, Placebo-Controlled Trial

✍ Christiane Bode; Christian Schäfer; Hiroshi Fukui; J. Christian Bode 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

A double-blind, multicenter trial compar

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

✍ Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Gol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Efficacy and safety of treatment with si

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

✍ R. Arechavaleta; T. Seck; Y. Chen; K. J. Krobot; E. A. O’Neill; L. Duran; K. D. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Inhibition of neutrophil migration soon

Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: Findings in a prospective, randomized, double-blind clinical trial in fifteen patients

✍ Maarten C. Kraan; Ben M. De Koster; Jan G. R. Elferink; Wendy J. Post; Ferdinand 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Leflunomide is a novel immunomodulating drug that has recently been approved as a disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA). The aim of this study was to determine the relationship between the clinical effects of leflunomide and neutrophil migration. Method